Previous 10 | Next 10 |
HQL pays regular quarterly dividends with a close to double digit yield, and despite poor price growth over medium and long run, HQL’s total return is impressive. In the past three months, a dividend cut and extension of buyback period played a significant role in price movemen...
Healthcare is an undervalued and inflation-resistant sector with a significant cash flow moat. Individual securities carry substantial risk and can be hard to understand and evaluate their competitive advantage. Billionaires are building in-house expertise and loading up on health...
Being financially independent is a must for retirees but can be desirable even for folks who are much younger and are several years away from retirement. We will go over our thesis as to how a diversified income portfolio with an in-built hedging mechanism with low volatility could ma...
While primarily focused on CEFs, my investment portfolio also includes ETFs/ETNs and some individual stocks in order to broaden the range of sectors covered. It currently consists of 32 securities, divided into three distinct groups, each with a different investment strategy. Afte...
HQH has a strong and steady dividend history, supported by its earnings. HQH’s stock has performed poorly over the past 5 years, but over the long run it has generated stable price growth. Current price multiples and NAV indicates HQH is trading at a discount. For fur...
This is one way closed-end funds can grow their total share count, contrary to the "closed" part of their structure. When utilizing a dividend reinvestment plan or DRIP, it is generally a win-win-win scenario for all involved. Many DRIPs are implemented in the same manner, with th...
BME is highly concentrated on large caps, but it is yet to recover from the pandemic. It has low dividend yield, thus not suitable for income-seeking investors. Short- and medium-term returns are low when compared with its peers. For further details see: BME: High Concen...
FBT is a passive biotechnology ETF, which doesn’t pay any dividend. Baring the past one year, FBT’s price return has outperformed the S&P 500. Effective portfolio rebalancing may determine its future growth. For further details see: FBT: A Long Term Hol...
Tekla Healthcare Investors (NYSE:HQH) declares $0.48/share quarterly dividend, -5.9% decrease from prior dividend of $0.51. Forward yield 9.15% Payable March 31; for shareholders of record Feb. 25; ex-div Feb. 24. See HQH Dividend Scorecard, Yield Chart, & Dividend Growth. For further d...
The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech. After the sell-off, biotech companies' valuation is close to the 2018 level even tho...
News, Short Squeeze, Breakout and More Instantly...
Tekla Healthcare Investors Company Name:
HQH Stock Symbol:
NYSE Market:
2024-04-22 03:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 07:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-23 06:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...